Gary Blackford resigns from Board effective March 15; Audit Committee short one member

Vyome Holdings, Inc

Gary Blackford resigned from the Board and all committees effective March 15, 2025; not due to any disagreement with the Company.
Audit Committee now has only two independent directors, violating Nasdaq Listing Rule 5605(c)(2)(A) requiring three.
Company will rely on Nasdaq cure period under Rule 5605(c)(4)(B) to regain compliance with audit committee composition.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Gary Blackford

Director

HIND · Vyome Holdings, Inc

Effective: 2025-03-15
Filed: March 20, 2025, 7:59 PM ET

Gary Blackford informed the Board of Directors (the “Board”) of ReShape Lifesciences Inc. (the “Company”) of his decision to resign from the Board and all related committees effective March 15, 2025.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Gary Blackford resigned as Director at Vyome Holdings, Inc.

Action: resigned
Role: Director

Exact text from the filing

Gary Blackford informed the Board of Directors (the “Board”) of ReShape Lifesciences Inc. (the “Company”) of his decision to resign from the Board and all related committees effective March 15, 2025.

View on SEC.gov

Vyome Holdings, Inc filing history →

Source: SEC EDGAR

accession 0001104659-25-026123

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.